FDA Approves Kal éo’s Auvi-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

Richmond, VA (November 20, 2017) kal éo, a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Auvi-Q (epinephrine injection, USP) 0.1...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news